HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Holders from Q3 2023 to Q1 2025

CUSIP
40637HAF6
Type / Class
Debt / NOTE 1.000% 8/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
672M
Holdings value
$729M
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
77
Number of buys
33
Number of sells
-33
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Period Principal Value Change Price Investors
2025 Q1 $7.25M $8.98M +$901K $1.28 4
2024 Q4 $672M $729M -$63.1M $1.08 77
2024 Q3 $680M $810M +$105M $1.19 75
2024 Q2 $24B $717M +$791K $1.11 72
2024 Q1 $18.9B $642M -$1.98B $0.97 71
2023 Q4 $18.9B $650M +$51.3M $0.93 71
2023 Q3 $15.8B $632M +$552M $0.94 63